Jakobsson S W, Okita R T, Mock N I, Masters B S, Buja L M, Prough R A
Acta Pharmacol Toxicol (Copenh). 1982 May;50(5):332-41. doi: 10.1111/j.1600-0773.1982.tb00984.x.
The cytochrome P-450-dependent monooxygenase system was examined in microsomal fractions prepared from 42 post mortem human livers and 9 lungs and kidneys. Electron microscopy studies indicated that the human liver samples were relatively free of mitochondrial and plasma membrane contamination, but samples of kidney and lung were less pure. The microsomal fractions from all organs were judged to be relatively free of haemoglobin and methaemoglobin. The specific enzyme activities for several drug substrates for the monooxygenase, NADPH-cytochrome c reductase activity and the content of the microsomal cytochromes were measured. The values of the biochemical parameters studied were found to be quite variable and the values for the human liver were appreciably lower than those obtained with liver microsomes from laboratory rodents. The enzyme activities of the human kidney and lung microsomal fractions were 1-10% of those seen for human liver samples, except for NADPH-cytochrome c(P-450) reductase activity. In order to evaluate any post mortem changes in human liver, correlations between drug metabolism activities and either cytochrome P-450 or NADPH-cytochrome c (P-450) reductase content were examined. Strong correlations (r greater than 0.91) were seen only between aminopyrine or ethylmorphine demethylase activity and cytochrome P-450 content in samples obtained within 4 hours of death. Longer post mortem times gave poorer correlation between activity and cytochrome content. These studies document several conditions required in order to obtain human microsomal fractions representative of the activities in fresh, viable tissue.
对从42例人类尸检肝脏以及9例肺和肾脏中制备的微粒体部分进行了细胞色素P - 450依赖性单加氧酶系统研究。电子显微镜研究表明,人类肝脏样本相对没有线粒体和质膜污染,但肾脏和肺的样本纯度较低。所有器官的微粒体部分被判定相对没有血红蛋白和高铁血红蛋白。测量了单加氧酶几种药物底物的比酶活性、NADPH - 细胞色素c还原酶活性以及微粒体细胞色素的含量。研究的生化参数值变化很大,人类肝脏的值明显低于从实验室啮齿动物肝脏微粒体获得的值。人类肾脏和肺微粒体部分的酶活性是人类肝脏样本的1% - 10%,NADPH - 细胞色素c(P - 450)还原酶活性除外。为了评估人类肝脏的任何死后变化,研究了药物代谢活性与细胞色素P - 450或NADPH - 细胞色素c(P - 450)还原酶含量之间的相关性。仅在死亡后4小时内获得的样本中,氨基比林或乙基吗啡脱甲基酶活性与细胞色素P - 450含量之间观察到强相关性(r大于0.91)。死后时间越长,活性与细胞色素含量之间的相关性越差。这些研究记录了为获得代表新鲜、有活力组织中活性的人类微粒体部分所需的几个条件。